4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001498428-26-000002
CEO & President sold 2,683 shares at $18.33 ($49,179)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cox John · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-16 | Sale : show line 1 in the form 10b5-1 | −2,683 | $18.33 | $49,179 | 368,151 | D |
| Open-market sales · 2,683 sh · avg $18.33 · $49,179 | ||||||
Loading xslF345X06/ownership.xml…